All Stories

  1. Identification of potentially anti-COVID-19 active drugs using the connectivity MAP

    Article • PLoS ONE, January 2022, PLOS

    Peyron Jean-Francois

  2. Leukemic mitochondrial transfer generates resistance to chemotherapy

    Article • Blood, June 2016, American Society of Hematology

    Peyron Jean-Francois

  3. Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients

    Article • Cancer Research, March 2016, American Association for Cancer Research (AACR)

    Peyron Jean-Francois

  4. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells

    Article • Leukemia, April 2015, Nature

    Peyron Jean-Francois

  5. Essential amino acids starvation to kill leukemia

    Article • Leukemia, December 2014, Nature

    Peyron Jean-Francois

  6. Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia

    Article • Cancer Letters, May 2014, Elsevier

    Peyron Jean-Francois

  7. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells

    Article • Cancer Letters, August 2013, Elsevier

    Peyron Jean-Francois

  8. Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas

    Article • Cancer Letters, June 2013, Elsevier

    Peyron Jean-Francois

  9. AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells

    Article • Oncogene, November 2003, Nature

    Peyron Jean-Francois

  10. Monitoring NF-κB Transactivation Potential Via Real-Time PCR Quantification of IκB-α Gene Expression

    Article • Molecular Diagnosis, September 2003, Springer Science + Business Media

    Peyron Jean-Francois

  11. Blocking NF-κB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector

    Article • Oncogene, May 2002, Nature

    Peyron Jean-Francois

  12. Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

    Article • Cell, September 1996, Elsevier

    Peyron Jean-Francois

  13. Immunofluorescent quantification of tyrosine phosphorylation of cellular proteins in whole cells by flow cytometry

    Article • Cytometry, April 1994, Wiley

    Peyron Jean-Francois

  14. The CD45 protein tyrosine phosphatase is required for the completion of the activation program leading to lymphokine production in the Jurkat human T cell line

    Article • International Immunology, January 1991, Oxford University Press (OUP)

    Peyron Jean-Francois